CN103656112A - Traditional Chinese medicine for treating postnatal galactostasis - Google Patents
Traditional Chinese medicine for treating postnatal galactostasis Download PDFInfo
- Publication number
- CN103656112A CN103656112A CN201210332329.9A CN201210332329A CN103656112A CN 103656112 A CN103656112 A CN 103656112A CN 201210332329 A CN201210332329 A CN 201210332329A CN 103656112 A CN103656112 A CN 103656112A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- galactostasis
- traditional chinese
- boar
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine for treating postnatal galactostasis. The traditional Chinese medicine comprises the following Chinese medicinal materials by weight: 35-65g of crude astragalus, 5-25g of Chinese angelica, 3-18g of common anemarrhena, 6-24g of scrophularia, 4-24g of pangolin, 12-32g of beautiful sweetgum fruit, 4-24g of towel gourd vegetable sponge and a pair of boar forehoofs. The traditional Chinese medicine for treating postnatal galactostasis is mainly used for treating postnatal galactostasis which influence lactation of a baby. After being taken, the traditional Chinese medicine can promote lactation, avoids manual lactation and has no side effects on the baby.
Description
Technical field
The present invention relates to a kind of Chinese medicine, relate in particular to galactostasis Chinese medicine after a kind of managing property.
Background technology
Breast milk is concerning baby, all more nutritious than any milk powder, if there is no milk feeding infant puerperal, will affect baby's body development and grow up healthy and sound, also always perplexing some young mothers without milk puerperal, and now treatment be mostly to eat of Western medicine, the mass formation impact of multipair milk, and expense is high.If adopt the meeting for the treatment of by Chinese herbs effect better.
Summary of the invention
The object of this invention is to provide a kind of have allow galactostasis Chinese medicine after the managing property of breast lactogenesis effect.
For realizing above object of the present invention, the present invention adopts following technical scheme:
The present invention is a kind of manage property after galactostasis Chinese medicine, its Chinese crude drug weight ratio ingredient is: Radix Astragali 35～65g, Radix Angelicae Sinensis 5～25g, the Rhizoma Anemarrhenae 3～18g, Radix Scrophulariae 6～24g, Squama Manis 4～24g, Fructus Liquidambaris 12～32g, Retinervus Luffae Fructus 4～24g, boar forehoof is a pair of.
The present invention is a kind of manage property after galactostasis Chinese medicine, its Chinese crude drug weight ratio ingredient is: Radix Astragali 40～60g, Radix Angelicae Sinensis 10～20g, the Rhizoma Anemarrhenae 6～16g, Radix Scrophulariae 9～20g, Squama Manis 6～20g, Fructus Liquidambaris 16～30g, Retinervus Luffae Fructus 8～20g, boar forehoof is a pair of.
The present invention is a kind of manage property after galactostasis Chinese medicine, its Chinese crude drug weight ratio ingredient is: Radix Astragali 45～55g, Radix Angelicae Sinensis 15～20g, the Rhizoma Anemarrhenae 10～15g, Radix Scrophulariae 12～18g, Squama Manis 8～16g, Fructus Liquidambaris 20～25g, Retinervus Luffae Fructus 10～15g, boar forehoof is a pair of.
The present invention is a kind of manage property after the use step of galactostasis Chinese medicine, serve on 3 pairs our first course for the treatment of, serve on 3 to 5 pairs second course for the treatment of, that with boar forehoof, boils every night removes one pair of oily soup decoction.
Take beneficial effect of the present invention: galactostasis Chinese medicine after a kind of managing property, cure mainly lactogenesis not in puerperal, puerperal is lactogenesis not, can affect baby's suckling, takes this prescription, can allow breast lactogenesis, and does not need artificial lactogenic, without on the unsound impact of baby.
The specific embodiment
Below in conjunction with embodiment more specifically, the present invention is done to further expansion explanation, but after it is pointed out that of the present invention managing property, galactostasis Chinese medicine is not limited to this concrete component or form.
Formula one:
Radix Astragali 35～65g, Radix Angelicae Sinensis 5～25g, the Rhizoma Anemarrhenae 3～18g, Radix Scrophulariae 6～24g, Squama Manis 4～24g, Fructus Liquidambaris 12～32g, Retinervus Luffae Fructus 4～24g, boar forehoof is a pair of.
Formula two:
Radix Astragali 40～60g, Radix Angelicae Sinensis 10～20g, the Rhizoma Anemarrhenae 6～16g, Radix Scrophulariae 9～20g, Squama Manis 6～20g, Fructus Liquidambaris 16～30g, Retinervus Luffae Fructus 8～20g, boar forehoof is a pair of.
Formula three:
Radix Astragali 45～55g, Radix Angelicae Sinensis 15～20g, the Rhizoma Anemarrhenae 10～15g, Radix Scrophulariae 12～18g, Squama Manis 8～16g, Fructus Liquidambaris 20～25g, Retinervus Luffae Fructus 10～15g, boar forehoof is a pair of.
We serve on 3 pairs first course for the treatment of, serve on 3 to 5 pairs second course for the treatment of, and that with boar forehoof, boils every night removes one pair of oily soup decoction.
Galactostasis Chinese medicine after of the present invention managing property, adopts effect that described various Chinese medicine has and effect respectively: Radix Astragali: QI invigorating is enriched blood; Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation; The Rhizoma Anemarrhenae: promoting diuresis to eliminate damp pathogen, spleen invigorating, calms the nerves; Radix Scrophulariae: clearing away heat and cooling blood, replenishing YIN and removing heat; Squama Manis: promoting blood circulation to remove blood stasis, current meridians; Fructus Liquidambaris: restore menstrual flow and invigorate blood circulation; Retinervus Luffae Fructus: dredge the meridian passage, heat-clearing and toxic substances removing, inducing diuresis to remove edema, hemostasis.
Treatment example 1:
He Yang, female, people from Hefei ,Anhui, 25 years old, takes front symptom: puerperal lactation deficiency juice, to take after 3 pairs, this Chinese medicine, milk increases, then takes 5 pairs, and milk increases.
Treatment example 2:
Liu Mei, female, people from Bengbu, 26 years old, takes front symptom: puerperal is without milk, takes after 3 pairs, this Chinese medicine, and milk increases, then takes 3 pairs, and milk increases.
Treatment example 3:
Yang Ni, female, Anhui six peace people, 28 years old, take front symptom: puerperal is without milk, take after 3 pairs, this Chinese medicine, and milk increases, then takes 5 pairs, and milk increases.
Although above the specific embodiment of the present invention has been given to describe in detail and explanation; but what should indicate is; we can carry out various equivalences to above-mentioned embodiment according to conception of the present invention and change and revise; when its function producing does not exceed spiritual that description contains yet, all should be within protection scope of the present invention.
Claims (4)
1. a galactostasis Chinese medicine after managing property, is characterized in that: its Chinese crude drug weight ratio ingredient is: Radix Astragali 35～65g, Radix Angelicae Sinensis 5～25g, the Rhizoma Anemarrhenae 3～18g, Radix Scrophulariae 6～24g, Squama Manis 4～24g, Fructus Liquidambaris 12～32g, Retinervus Luffae Fructus 4～24g, boar forehoof is a pair of.
2. galactostasis Chinese medicine after according to claim 1 managing property, is characterized in that: its Chinese crude drug weight ratio ingredient is: Radix Astragali 40～60g, Radix Angelicae Sinensis 10～20g, the Rhizoma Anemarrhenae 6～16g, Radix Scrophulariae 9～20g, Squama Manis 6～20g, Fructus Liquidambaris 16～30g, Retinervus Luffae Fructus 8～20g, boar forehoof is a pair of.
3. galactostasis Chinese medicine after according to claim 2 managing property, it is characterized in that: its Chinese crude drug weight ratio ingredient is: Radix Astragali 45～55g, Radix Angelicae Sinensis 15～20g, the Rhizoma Anemarrhenae 10～15g, Radix Scrophulariae 12～18g, Squama Manis 8～16g, Fructus Liquidambaris 20～25g, Retinervus Luffae Fructus 10～15g, boar forehoof is a pair of.
4. the use step of galactostasis Chinese medicine after according to claim 1 managing property, is characterized in that: serve on 3 pairs our first course for the treatment of, serve on 3 to 5 pairs second course for the treatment of, and that with boar forehoof, boils every night removes one pair of oily soup decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210332329.9A CN103656112A (en) | 2012-09-11 | 2012-09-11 | Traditional Chinese medicine for treating postnatal galactostasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210332329.9A CN103656112A (en) | 2012-09-11 | 2012-09-11 | Traditional Chinese medicine for treating postnatal galactostasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103656112A true CN103656112A (en) | 2014-03-26 |
Family
ID=50295671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210332329.9A Pending CN103656112A (en) | 2012-09-11 | 2012-09-11 | Traditional Chinese medicine for treating postnatal galactostasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103656112A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104382028A (en) * | 2014-11-28 | 2015-03-04 | 于华华 | Health porridge product with effect of enhancing lactation promotion after delivery of women and making method |
| CN104382029A (en) * | 2014-11-28 | 2015-03-04 | 于华华 | Carp porridge capable of improving lactation obstruction of women after delivery and production method of carp porridge |
| CN104887915A (en) * | 2015-06-28 | 2015-09-09 | 臧海阳 | Traditional Chinese medicine composition for treating liver-qi stagnation type breast milk obstruction |
| CN104887914A (en) * | 2015-06-28 | 2015-09-09 | 臧海阳 | Qi and blood deficiency and liver-qi stagnation type breast milk stoppage treatment traditional Chinese medicine compound |
| CN104888020A (en) * | 2015-06-24 | 2015-09-09 | 臧海阳 | Traditional Chinese medicine composition for treatment of breast milk obstruction caused by deficiency of qi and blood |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101380381A (en) * | 2008-09-27 | 2009-03-11 | 刘运波 | Traditional Chinese medicine for treating hypogalactia |
| CN101700352A (en) * | 2009-11-11 | 2010-05-05 | 丁常燕 | Traditional Chinese medicine for treating hypogalactia |
-
2012
- 2012-09-11 CN CN201210332329.9A patent/CN103656112A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101380381A (en) * | 2008-09-27 | 2009-03-11 | 刘运波 | Traditional Chinese medicine for treating hypogalactia |
| CN101700352A (en) * | 2009-11-11 | 2010-05-05 | 丁常燕 | Traditional Chinese medicine for treating hypogalactia |
Non-Patent Citations (1)
| Title |
|---|
| 江克明等: "《简明方剂辞典》", 28 February 1989 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104382028A (en) * | 2014-11-28 | 2015-03-04 | 于华华 | Health porridge product with effect of enhancing lactation promotion after delivery of women and making method |
| CN104382029A (en) * | 2014-11-28 | 2015-03-04 | 于华华 | Carp porridge capable of improving lactation obstruction of women after delivery and production method of carp porridge |
| CN104382029B (en) * | 2014-11-28 | 2016-09-07 | 周少红 | Improve carp congee and the preparation method of women's alactation in postpartum |
| CN104382028B (en) * | 2014-11-28 | 2017-01-04 | 湖南友乾互联网科技有限公司 | Promote the health care gruel stimulated the secretion of milk puerperal of women and preparation method |
| CN104888020A (en) * | 2015-06-24 | 2015-09-09 | 臧海阳 | Traditional Chinese medicine composition for treatment of breast milk obstruction caused by deficiency of qi and blood |
| CN104887915A (en) * | 2015-06-28 | 2015-09-09 | 臧海阳 | Traditional Chinese medicine composition for treating liver-qi stagnation type breast milk obstruction |
| CN104887914A (en) * | 2015-06-28 | 2015-09-09 | 臧海阳 | Qi and blood deficiency and liver-qi stagnation type breast milk stoppage treatment traditional Chinese medicine compound |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN103393879B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency | |
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN103028091B (en) | Traditional Chinese medicine composition for treating damp heat of liver and gallbladder | |
| CN102000301A (en) | Traditional Chinese medicine composite for treating mammitis and lobular hyperplasia of mammary gland and preparation method thereof | |
| CN103656112A (en) | Traditional Chinese medicine for treating postnatal galactostasis | |
| CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
| CN104922281A (en) | Traditional Chinese medicine composition of patch-type ointment for treating slow-transit constipation and preparation method thereof | |
| CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
| CN101897930A (en) | Chinese medicinal herb for treating dysmenorrhoea disease | |
| CN104606514A (en) | Traditional Chinese medicine composition for treating kidney deficiency type tinnitus | |
| CN104740288A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN103599358A (en) | Anti-constipation herbal tea formula | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN103055072B (en) | Traditional Chinese medicine composition for treating stranguria | |
| CN105477619A (en) | Traditional Chinese medicine composition for treating delayed menorrhea | |
| CN104225348A (en) | Traditional Chinese medicine for treating cholelithiasis | |
| CN103211998B (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN104784399A (en) | Traditional Chinese medicine composition for treating rash | |
| CN105943744A (en) | Traditional Chinese medicine composition for treating retention of urine | |
| CN105560887A (en) | Medicine for treating constipation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Xiankui Document name: the First Notification of an Office Action |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140326 |